Literature DB >> 21864317

Patterns of p53 immunoreactivity in endometrial carcinomas: 'all or nothing' staining is of importance.

W Glenn McCluggage, Robert A Soslow, C Blake Gilks.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21864317     DOI： 10.1111/j.1365-2559.2011.03907.x

Source DB:  PubMed          Journal:  Histopathology        ISSN： 0309-0167            Impact factor:   5.087


× No keyword cloud information.
  17 in total

Review 1.  Practical issues in the diagnosis of serous carcinoma of the endometrium.

Authors:  Sonia Gatius; Xavier Matias-Guiu
Journal:  Mod Pathol       Date:  2016-01       Impact factor: 7.842

2.  A Detailed Immunohistochemical Analysis of a Large Series of Cervical and Vaginal Gastric-type Adenocarcinomas.

Authors:  Claire Carleton; Lien Hoang; Shatrughan Sah; Takako Kiyokawa; Yevgeniy S Karamurzin; Karen L Talia; Kay J Park; W Glenn McCluggage
Journal:  Am J Surg Pathol       Date:  2016-05       Impact factor: 6.394

Review 3.  Data set for reporting of ovary, fallopian tube and primary peritoneal carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR).

Authors:  W Glenn McCluggage; Meagan J Judge; Blaise A Clarke; Ben Davidson; C Blake Gilks; Harry Hollema; Jonathan A Ledermann; Xavier Matias-Guiu; Yoshiki Mikami; Colin J R Stewart; Russell Vang; Lynn Hirschowitz
Journal:  Mod Pathol       Date:  2015-06-19       Impact factor: 7.842

4.  The clinicopathologic significance of p53 and BAF-250a (ARID1A) expression in clear cell carcinoma of the endometrium.

Authors:  Oluwole Fadare; Katja Gwin; Mohamed M Desouki; Marta A Crispens; Howard W Jones; Dineo Khabele; Sharon X Liang; Wenxin Zheng; Khaled Mohammed; Jonathan L Hecht; Vinita Parkash
Journal:  Mod Pathol       Date:  2013-03-22       Impact factor: 7.842

5.  Genomic profiling of malignant phyllodes tumors reveals aberrations in FGFR1 and PI-3 kinase/RAS signaling pathways and provides insights into intratumoral heterogeneity.

Authors:  Su-Yang Liu; Nancy M Joseph; Ajay Ravindranathan; Bradley A Stohr; Nancy Y Greenland; Poonam Vohra; Elizabeth Hosfield; Iwei Yeh; Eric Talevich; Courtney Onodera; Jessica A Van Ziffle; James P Grenert; Boris C Bastian; Yunn-Yi Chen; Gregor Krings
Journal:  Mod Pathol       Date:  2016-06-03       Impact factor: 7.842

6.  TP53 Mutational Spectrum in Endometrioid and Serous Endometrial Cancers.

Authors:  Anne M Schultheis; Luciano G Martelotto; Maria R De Filippo; Salvatore Piscuglio; Charlotte K Y Ng; Yaser R Hussein; Jorge S Reis-Filho; Robert A Soslow; Britta Weigelt
Journal:  Int J Gynecol Pathol       Date:  2016-07       Impact factor: 2.762

7.  A "Null" Pattern of p16 Immunostaining in Endometrial Serous Carcinoma: An Under-recognized and Important Aberrant Staining Pattern.

Authors:  Daniel R Matson; Molly A Accola; Les Henderson; Xiangqiang Shao; Leah Frater-Rubsam; Vanessa L Horner; William M Rehrauer; Paul Weisman; Jin Xu
Journal:  Int J Gynecol Pathol       Date:  2021-08-11       Impact factor: 3.326

8.  Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative.

Authors:  Ellen Stelloo; Tjalling Bosse; Remi A Nout; Helen J MacKay; David N Church; Hans W Nijman; Alexandra Leary; Richard J Edmondson; Melanie E Powell; Emma J Crosbie; Henry C Kitchener; Linda Mileshkin; Pamela M Pollock; Vincent T Smit; Carien L Creutzberg
Journal:  Mod Pathol       Date:  2015-02-27       Impact factor: 7.842

9.  Low Grade Papillary Sinonasal (Schneiderian) Carcinoma: A Series of Five Cases of a Unique Malignant Neoplasm with Comparison to Inverted Papilloma and Conventional Nonkeratinizing Squamous Cell Carcinoma.

Authors:  Mario W Saab-Chalhoub; Xingyi Guo; Qiuying Shi; Rebecca D Chernock; James S Lewis
Journal:  Head Neck Pathol       Date:  2021-05-26

10.  Measuring the biological effect of presurgical metformin treatment in endometrial cancer.

Authors:  V N Sivalingam; S Kitson; R McVey; C Roberts; P Pemberton; K Gilmour; S Ali; A G Renehan; H C Kitchener; E J Crosbie
Journal:  Br J Cancer       Date:  2016-01-21       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.